Skip to main content

Author: Johnny Green

Jersey Campaign Highlights How Cannabis Has Gone Mainstream In Germany

One area of society that cuts across political lines and socioeconomic backgrounds is sports. People from all walks of life love sports, with football (soccer) being the most popular sport around the world. Football is especially popular in Europe where hundreds of millions of fans are located.

With that in mind, it was a very big deal when the “Endlich” special jersey campaign was recently launched by SC Paderborn 07, Four 20 Pharma, and the Sanity Group, with part of the campaign involving pro-cannabis messaging being prominently placed at a recent football match.

Sport-Club Paderborn 07 e.V., commonly known as SC Paderborn 07 or SC Paderborn, is a German association football club based in Paderborn, North Rhine-Westphalia.

“Whether it’s the 2nd Bundesliga, Bundesliga or international football: special jerseys have become established and are often a real collector’s item for fans of the respective teams. They are usually issued for a special occasion such as a Champions League game. But sometimes they also have a much more serious background – as with the “Endlich” special jersey campaign by SC Paderborn 07, Four 20 Pharma GmbH (Four 20 Pharma) and the Sanity Group.” Four 20 Pharma GmbH stated about the effort.

“The jersey, which is all green with white accents and in which the SC Paderborn 07 team played against Jahn Regensburg, aims to draw attention to the issue of medicinal cannabis and counteract possible stigmatization and prejudice. There were also a variety of activities in and around the stadium – for example information stands and flyers on the seats.” the company also stated.

Below is footage from the match:

“The SCP07 team came onto the pitch dressed entirely in green and with a striking “Endlich” lettering and presented the jersey to the fans. During halftime, the special jerseys were then distributed using a “jersey cannon”. The oversized, inflatable jersey in the “Endlich” design on the forecourt was also an eye-catcher and a popular photo motif.” Four 20 Pharma GmbH stated.

“The other offers from the Endlich initiative were more informative – for example, the interior interview before the game or the 15,000 flyers that were distributed throughout the stadium and conveyed facts about the topic of medicinal cannabis and drew attention to a special Endlich Instagram filter. At information stands, visitors could also talk to medicinal cannabis experts, learn important facts and clarify questions.” they also stated.

Such a powerful message in such a mainstream setting is a big deal by every measure. Putting pro-cannabis messaging on such a grand stage no doubt reached parts of society that other pro-cannabis efforts simply cannot reach. It is an unparalleled effort that will reduce the stigma surrounding cannabis in Germany and beyond.

“After all, this is how we get into conversation with people who have not yet dealt with the topic or have not dealt with it sufficiently, or who are generally opposed to it. And that is exactly where we want to start: initiate a factual discussion, take the topic out of the dirty corner.” says Finn Hänsel, Managing Director & Founder of the Sanity Group.

“The feedback was overall positive, similar to the presentation of Four 20 Pharma as the main and jersey sponsor. We were happy to support this and with the joint special jersey campaign we helped to bring it even more into the public eye and to remove the taboo.” said Martin Hornberger, SCP 07 managing director.

The effort was also supported by TV presenter Matthias Killing (Sat.1 breakfast television), influencer Max Büchsenschütz, and professional athlete and motocross rider Tristan Hanak, who all participated in the campaign.

CBD Skincare Market Expected To Experience Tremendous Growth

The overall cannabidiol (CBD) industry has experienced significant growth in recent years due to regulatory reforms and increased demand by consumers and patients. One sector that is witnessing the most growth is the CBD skincare market, which is projected to expand considerably in the coming years.

According to a recent market analysis by Allied Market Research, the global CBD skincare market is projected to reach $8.9 billion in value by 2033, a CAGR of 19.5%. The same market analysis estimates that the CBD skincare market was valued at $1.5 billion in 2023.

“Continuous innovation and new product launches by major skincare brands are attracting consumers and expanding the market. The influence of social media and celebrity endorsements is further enhancing market growth.” the researchers stated.

“Moreover, the increased availability of CBD skincare products through various retail channels, including online stores, specialty beauty shops, and health stores, is facilitating market expansion.” the researchers also stated.

A separate recent market analysis by SNS Insider also projects that the CBD skincare market will experience tremendous growth in the near future. According to SNS Insider, the CBD skincare market will be worth a projected $22.19 billion by 2032, a CAGR of 28.7%.

“Industry reports suggest that CBD skincare products are going to move upward, as growing awareness regarding the anti-inflammatory and antioxidant effects of CBD is entering as one of the largest most sought-after ingredients in modern skincare routines.” SNS Insider stated about the CBD skincare market. The market researchers also determined the following:

  • In 2023, the oils segment accounted for over 38.8 % of the total market share in the CBD skincare market
  • The segment of department stores had the highest share, above 29.0% in 2023
  • Hemp-based products topped the market with over 63.5% share in the year 2023
  • North America was established as a market leader in the CBD skincare product market in 2023

Additionally, according to a recent analysis by Research and Markets, the CBD nutraceuticals market will be worth an estimated $29.1 billion by 2030. The market analysis estimates that the CBD nutraceuticals market will be worth $9.7 billion in 2024.

Germany’s Agriculture Ministry Approves Historic Hemp Measure

Germany recently approved a draft law previously presented by the Federal Minister of Food and Agriculture Cem Özdemir. The approved measure liberalizes industrial hemp in Germany and is intended to make it easier to cultivate industrial hemp and permit its use.

As part of the measure, the ‘abuse clause’ will be deleted and the indoor cultivation of industrial hemp will be expressly legal.

“Especially in times of climate crisis, we are removing obstacles from the path of farmers who want to try something new in their fields or in their halls. Industrial hemp offers our agriculture many opportunities: It contains hardly any THC, which causes highs, is undemanding, requires hardly any pesticides, fertilizers or water, improves soil and provides a habitat for insects.” Minister Özdemir stated.

“The harvest can be processed in a wide variety of ways, from food to textiles. The abuse clause criminalized actually innocent industrial hemp growers despite their best intentions. Now it is finally time to let the grass grow over it. And a lot of it, if possible, so that the innovative scene of industrial hemp growers and processors can continue to develop in Germany too.” Minister Özdemir also stated.

The German Cannabis Industry Association (BvCW) welcomed the central elements of the reform in its recent newsletter.

“Until now, even the theoretical possibility of a slight intoxication through the private consumption of large quantities of products has led to the entire value chain being punishable. This special German regulation is now being abolished.” BvCW stated about the recently approved measure.

“We are finally freed from these unnecessary hurdles. This is a major political step forward for industrial hemp and will contribute significantly to the growth of the industry.” Marijn Roersch van der Hoogte, Department Coordinator for industrial hemp at BvCW, stated.

“We are pleased about this important step and will actively support the further parliamentary process.” Jürgen Neumeyer, Managing Director of BvCW, commented.

BvCW pointed out in its coverage of the approved hemp measure the need for further hemp policy and regulatory changes in Germany, including raising the THC limit from 0.3 to 1.0% and providing funding and standardizing measurement methods for cannabinoid values.

“After the legalization of cannabis as a recreational drug, there is no longer any reason for many restrictions on the cultivation of industrial hemp. The Industrial Hemp Liberalization Act removes hurdles for hemp cultivation. In the parliamentary process, we will take a close look at whether the law is sufficient or whether it still needs to be improved. The potential of the plant as a supplier of oil and fiber is enormous. We should use it.” Karl Bär (The Greens) told BvCW.

UK Cannabis Legalization Could Generate £9.5 Billion Per Year

Legalizing cannabis for adult use in the United Kingdom and taxing and regulating sales could generate as much as £9.5 billion per year according to a new analysis published by CLEAR. CLEAR is a cannabis reform advocacy organization based in the UK.

“Overall the net benefit to the taxpayer of a taxed and regulated cannabis market could range from £3.4 Billion to £9.5 Billion per annum, with a best estimate of £6.7 Billion per year at recent market levels.” the organization stated.

The market projection is part of a recently published analysis by CLEAR titled, ‘How to Regulate Cannabis in Britain.’ The recently published analysis is the third version of the organization’s plan, with the first version being published on September 12th, 2011, and the second version being published on October 18th, 2013.

“The plan is predicated on the fact that the prohibition of cannabis provides no control whatsoever over this multi-billion-pound market. Present policy is, in fact, an abdication of responsibility by government to organised crime.” CLEAR stated in its analysis.

CLEAR is proposing, among other things, the creation of an “inspectorate as an executive agency of government to include a head office, 10 analysis laboratories, 10 bonded warehouses, 10 regional offices, 100 local offices with a total of 2620 staff and an annual budget of around £200 million.”

“Wholesale distribution and retail licensing would be based on the tobacco/alcohol model. Licences would only be granted to a “fit and proper” person or company. Previous nonviolent cannabis convictions would not disqualify an applicant. There would be a duty of responsibility on retailers not to supply to someone obviously intoxicated on cannabis or any other substance. A limit of 10 grams per transaction could be considered although there is currently no limit on sales of alcohol which is a very much more dangerous drug. Sales would be to adults only and ID would be required if there was any doubt of the customer’s age.” CLEAR stated about its proposed regulated sales model.

In addition to legalized sales, CLEAR is also proposing the legalization of ‘cannabis cafes’ and ‘cannabis social clubs,’ as well as permitting adults to cultivate up to three plants ‘under artificial lighting’ and another three plants ‘under natural light.’

“Alternatively, without artificial lighting, a total of six plants under natural light. Also included would be a separate propagation area for cuttings and seedlings of up to one square metre.” CLEAR stated in its report.

Czech Republic’s Ministry Of Justice Proposes Legalizing Cannabis Cultivation

The Ministry of Justice in the Czech Republic is proposing that adults should be able to cultivate up to three plants in their private residences, in addition to possessing up to 25 grams when away from their residences and up to 50 grams in their homes.

“According to the draft of the new criminal regulations, which the ministry sent to the government for consideration, people over the age of 21 could grow cannabis for their own use.” Novinsky stated in its local reporting (translated from Czech to English).

“In this regard, the proposal reevaluates the question of what actions should be criminal at all, and liberalizes today’s regulation, where some of the actions today are considered criminal offenses and then legalizes some actions completely,” the ministry said in its preliminary report.

What is being proposed in Czechia is similar to what was implemented in Germany earlier this year from cultivation plant limit and possession limit standpoints, however, the proposed legal age of 21 years old differs from what Germany adopted and is similar to what is in place in two dozens states in the U.S.

In addition to the ministry’s proposal to legalize adult-use cultivation and possession, the ministry also wants to change Czechia’s laws to set a threshold of five cannabis plants, 100 grams of ‘dry matter when a person has it at home,’ or 50 grams when it is outside their home, as the difference between a lower offense and a crime.

The ministry’s proposal does not appear to include regional adult-use cannabis commerce pilot trials or cultivation associations, at least at this time. Cultivation associations are part of Germany and Malta’s legalization models, and Germany is pursuing the launch of pilot trials. Pilot trails are already operating in the Netherlands and Switzerland.

In July 2024, the International Cannabis Business Conference was provided a leaked document by local activists in Czechia of a policy modernization plan that included regional adult-use cannabis commerce pilot trials and cultivation associations.

“The current prohibition leads to the fact that there are more than a thousand people convicted of cannabis crimes in prisons, which burdens the state budget with costs of over CZK 700 million per year,” emphasized Tomáš Vymazal, a member of the Rational Regulation (RARE) board and chairman of the Safe Cannabis Association, in a press release provided to the International Cannabis Business Conference in July.

The Registered Association Rational Regulation (RARE) was established at the beginning of 2024 with the aim of supporting rational cannabis regulation in the Czech Republic based on scientific knowledge and the best foreign experience. Its founders are the Czech industry cluster CzechHemp, the Legalizace.cz association, and the Safe Cannabis Association, which ‘brings together producers, distributors, and consumers of hemp extracts and hemp products.’

“The new legislation would lead to a significant decrease in the number of persons prosecuted, convicted or imprisoned for possession and cultivation of cannabis, which would result in annual savings of up to 1.2 billion CZK.” Vymazal stated at the time.

A limiting factor in all legalized European nations, which will also presumably prove to be the case in Czechia to some extent, is current European Union agreements. EU policies limit the level of adult-use cannabis commerce that can be conducted within its member nations to cultivation associations and research pilot trials.

According to the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA), nearly 30% of Czech adults have consumed cannabis at least once in their lifetimes and 11.1% report having consumed cannabis within the last year. The average rate for once-a-year consumption across Europe is 8% according to EMCDDA data.

Global Cannabis Seeds Market Projected To Reach $6.5 Billion By 2031

The global cannabis seed market is projected to experience significant growth between now and 2031 according to a market report by Allied Market Research. The market researchers estimate that the value of the worldwide cannabis seed market was $1.3 billion in 2021 and that the sector’s value will increase to $6.5 billion by 2031 (a CAGR of 18.4%).

Increased demand for cannabis seeds is due to various factors, not the least of which is laws being modernized around the globe to permit the sales and purchases of cannabis seeds. A great example of that can be found in Germany where, as of April 1st, 2024, adults can cultivate up to three cannabis plants in their private residences.

Many German home cultivators are purchasing seeds to populate their home gardens. A recent YouGov poll in Germany found that 7% of poll participants indicated that they had already purchased cannabis seeds (or clones) since legalization took effect.

In addition to the 7% of poll participants indicating that they had already purchased cannabis genetics for their home gardens, another 11% of poll participants responded that they plan to purchase cannabis genetics in the future. Increased demand for cannabis seeds in Germany has resulted in booming sales among Europe’s seed banks.

Another part of the world where cannabis seeds are very popular is the United States. Currently, twenty-four states have adopted adult-use legalization laws in the U.S., as well as in Washington D.C. Not every jurisdiction permits home cultivation, however, most do, and many consumers are taking advantage of the recently afforded freedom.

In 2022, the DEA confirmed that cannabis seeds are legal now in the United States since they do not contain enough THC to be prohibited. Cannabis seeds are considered hemp under U.S. law, and hemp was legalized nationwide as part of the 2018 Farm Bill.

A great event dedicated to cannabis seeds is coming to San Francisco on December 7th-8th, 2024. More than 1,000 cannabis cultivators are expected to access the next generation of elite cannabis genetics at the first “Terpnami” seed fest in San Francisco. The event will feature over 20 cannabis seed breeders.

The public event is free to attend with RSVP and will be open from 11 a.m. to 4 p.m. Saturday, December 7th and Sunday, December 8th.

“Terpnami will feature fine food, drink, art, DJs, and festival attractions. A weekend of events including clone and seed drops at Bay Area dispensaries like 7 Stars, as well as VIP receptions wrap around the seed festival.” stated SFHashWeek in a recent blog post.

The event is organized by award-winning journalist and best-selling author David Downs. His ‘David Downs Presents’ production team brought more than 25 events to San Francisco in 2024, including the incredibly successful SF Weed Weeks and SF Hash Week.

“Everything in cannabis starts with great genetics and I’m honored to celebrate the breeders. Breeders are rockstars and deserve to be celebrated in a world-class city with a top-notch event. San Francisco in December is the perfect place for the cannabis genetics world to get together every year,” Downs said.

According to a recent survey conducted by The Harris Poll, most cannabis cultivators (61%) prefer to start their gardens with seeds. The study also found that:

  • 81% of cannabis consumers agree all Americans should have the right to grow at home
  • 62% of cannabis consumers would rather grow their own cannabis than buy it
  • 34% of cannabis consumers who have grown at home do so because they feel safer consuming their own home-grown flower compared to store-bought cannabis

When Will France Tap Its Cannabis Industry Market Potential?

As cannabis policy modernization efforts continue to gain momentum in Europe, and more European nations reform their outdated and harmful cannabis policies, one country that is on every cannabis advocate’s radar is France.

France is home to one of the largest cannabis consumer bases on earth. With a total population of roughly 68 million people, an estimated 10.6% of French adults reported having consumed cannabis within the last year according to a 2022 survey conducted by the French Observatory of Drugs and Addictive Tendencies in partnership with the Santé Publique France agency.

Applying the estimated cannabis usage rate to France’s adult population works out to potentially millions of adult cannabis consumers for an eventual legal adult-use market in France. Of course, many of the adults who report consuming cannabis in France are doing so for medical reasons and the market potential for an effective medical cannabis program in France is also huge.

In March 2021, France launched a limited medical cannabis experiment involving between 2,000 and 3,000 suffering patients to gain insight into possibly crafting national medical cannabis policies and regulations.

The French medical cannabis experiment received initial approval from the federal Senate back in 2019, however, the launch of the trial was delayed until the spring of 2021 due to various reasons. Cannabis producer LaFleur was eventually selected as the cultivator for the program and has supplied participating patients since the experiment’s launch.

Initially slated for two years, France’s medical cannabis experiment was eventually granted a one-year extension and was set to end in 2024. The program is now expected to end in 2025.

A national medical cannabis program was initially expected to launch in France in 2025, although, 2026 appears to be a more realistic timeline for the program’s launch. Meanwhile, adult-use cannabis reform is likely to occur further into the future in France. With that being said, cannabis activists in the country are doing everything they can to speed up both timelines.

Currently, cannabis is legal at a national level for adult use in three European countries – Malta, Luxembourg, and Germany. Additionally, regional adult-use cannabis commerce pilot trials are currently operating in the Netherlands and Switzerland, affording enrolled consumers a legal way to source their products.

Further delays in cannabis policy modernization in France come with an opportunity cost. If France institutes a regulated industry it could easily become a continental and international powerhouse.

Conversely, if lawmakers in France continue to drag their feet, the nation’s market potential will decrease with every passing year. Surrounding nations will gain a larger market share and their domestic cannabis companies will create advantages that will be hard for France-based companies to compete with.

To be clear, large numbers of cannabis consumers and patients consume cannabis every day in France, albeit illegally. French lawmakers would be wise to recognize this fact and work to transition the market from an unregulated one to a regulated one which would, among other things, boost positive public health outcomes.

The situation is fluid in France and it can be difficult for cannabis enthusiasts to navigate. A great opportunity to learn the latest and most important information about France’s shifting cannabis landscape is coming up next month in France at the Science in the City International event in Bordeaux on October 26th, 2024.

Science in the City International is a unique opportunity for international industry stakeholders, medical healthcare professionals, functional and integrative medicine practitioners, and community healthcare changemakers and leaders to come together for a historic event. It’s a great opportunity to learn and network with other like-minded people.

Germany Judiciary Examines Nearly 280,000 Past Cannabis Cases

Germany’s Judiciary recently announced that federal states have reviewed an estimated 279,000 past cannabis cases after adult-use legalization took effect in Germany on April 1st, 2024. Starting on April 1st, adult consumers in Germany can cultivate, possess, and consume cannabis within certain parameters.

“The most populous federal state, North Rhine-Westphalia, has the most reviews (86,000), followed by Bavaria (41,500) and Hesse (34,000). The smallest federal state, Bremen, has the fewest criminal records reviewed (531).” Augsburger Allgemeine reported (translated from German to English).

Cannabis prohibition previously cost Germany 1.3 billion euros a year according to an analysis by the Institute for Competition Economics (DICE) at the Heinrich Heine University in Duesseldorf. Reviewing old cannabis cases is a massive undertaking in Germany, and the huge number of reviews is a testament to how many lives were needlessly harmed in Germany due to prohibition.

“According to the evaluation, the judiciary in Bavaria has re-examined 41,500 cases, and the courts have so far received more than 6,200 cases for re-determination of sentences. The courts have already made a decision on this in around 3,500 cases. The Hessian authorities have already imposed sentences 450 times, and the sentence has been re-determined in a further 88 cases.” Augsburger Allgemeine also reported.

Meanwhile, in Bavaria, a reported 33 cannabis consumers have been recently released from incarceration thanks to Germany’s new cannabis laws.

“Since the partial legalization of cannabis on April 1, 2024, 33 incarcerated cannabis users have been released from prison in Bavaria.” stated the German Cannabis Business Association (BvCW) in a recent newsletter. The release of cannabis prisoners in Bavaria was first reported by Süddeutsche Zeitung.

In addition to cannabis being legal for adult use in Germany, recreational cannabis is also legal in Uruguay, Canada, Malta, Luxembourg, and South Africa, as well as at the local level in certain parts of the Netherlands, Switzerland, and the United States.

Cannabis Policy Modernization Measure Expected In Slovenia By End Of Year

According to Dr. Metka Paragi, a leading international microbiologist who currently serves as the Secretary for Health in the Cabinet of the Prime Minister of the Republic of Slovenia, lawmakers will introduce a cannabis policy reform measure in the Central European nation by the end of this year.

Dr. Paragi made the announcement at the recent International Cannabis Business Conference held in Bled Slovenia on September 13th, 2024. Earlier this year voters in Slovenia approved two cannabis referendum measures – one focusing on personal adult use decriminalization and another dealing with medical cannabis.

“We fulfill our promise with full responsibility and prepare modern European legislation that will give our citizens access to safe and professionally supported hemp products for health and well-being,” Dr. Paragi stated according to local reporting by N1 SLO. “The current Slovenian legislation allows the use of hemp products for medical purposes, but it has never really taken off. In practice, this manifests itself to a very limited extent and with many obstacles.”

Currently, cannabis is legal for adult use in Uruguay, Canada, Malta, Luxembourg, Germany, and South Africa. Recreational pilot trials are also in operation in a limited number of jurisdictions in the Netherlands and Switzerland. Cannabis is also legal for adult use in two dozen states in the U.S. as well as in Washington D.C. Medical cannabis laws have been adopted by at least 57 countries around the world.

Slovenia is uniquely positioned to fill a substantial void in the international cannabis industry’s research and development sector. Slovenia is already a top global hub for research and development efforts for other large industries, including the pharmaceutical industry, and the nation’s university facilities and leading researchers could develop cannabis products and delivery methods that would revolutionize the cannabis space.

“We should not underestimate how valuable a niche this activity can be for Slovenia,” said International Cannabis Business Conference co-founder and Executive Producer Alex Rogers. The International Cannabis Business Conference event held days ago in Bled was focused on emerging cannabis science and technology.

“In conjunction with the European elections on June 9, Slovenia also held three consultative referendums, including on cannabis. 66.71 percent voted for the cultivation and processing of cannabis for medical purposes, and 51.57 percent of the voters who submitted a valid ballot voted for the cultivation and possession of cannabis for limited personal use.” reported N1 SLO in its coverage.

The legal global cannabis industry is set for significant expansion in the coming years according to a recent market analysis by Skyquest Technology Consulting. The market researchers are projecting that the regulated worldwide cannabis market will surpass $148.4 billion in value by 2031.

“Cannabis market was valued at USD 36.4 Billion in 2022 and is poised to grow from USD 42.6 Billion in 2023 to USD 148.4 Billion by 2031, growing at a CAGR of 16.9% during the forecast period (2024-2031).” the company stated in a press release.

Suffering patients in Slovenia deserve to have safe access to medical cannabis therapies if their doctor deems it appropriate, just as they do in every other country around the world. Additionally, taxpayers in Slovenia deserve to not have precious public resources wasted on enforcing failed cannabis prohibition policies on consumers, and decriminalization is warranted.

Entrepreneurs and innovators in Slovenia should have the right to gain their share of the next great industry and to compete with other markets on a level playing field, which would, in turn, provide a major boost to Slovenia’s economy. Cannabis policy modernization in Slovenia is a win-win situation, and hopefully lawmakers recognize that as the political process moves along.